Galderma Group N (GALD) — Capital Reinvestment Ratio
Galderma Group N (GALD) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (CHF475.06 Million) in capital expenditures (CHF37.07 Million). Check how tangible is Galderma Group N's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Galderma Group N Capital Reinvestment Ratio (2021–2024)
This chart tracks Galderma Group N's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Galderma Group N (GALD) cash flow conversion.
Annual Capital Reinvestment Ratio for Galderma Group N (2021–2024)
Year-by-year Capital Reinvestment Ratio for Galderma Group N from 2021 to 2024. See how much free cash does Galderma Group N generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.64x | CHF429.77 Million | CHF275.00 Million | ▼ -6.8% |
| 2023 | 0.69x | CHF148.64 Million | CHF102.02 Million | ▼ -52.1% |
| 2022 | 1.43x | CHF106.30 Million | CHF152.33 Million | ▲ +119.1% |
| 2021 | 0.65x | CHF178.92 Million | CHF117.03 Million | — |